Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - flucloxacillin sodium monohydrate 1088.1mg equivalent to 1000 mg flucloxacillin - powder for injection - 1000 mg - active: flucloxacillin sodium monohydrate 1088.1mg equivalent to 1000 mg flucloxacillin - flucloxacillin kabi is indicated in adults and children for the following: - the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. - prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - flucloxacillin sodium monohydrate 544.1mg equivalent to 500 mg flucloxacillin - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 544.1mg equivalent to 500 mg flucloxacillin - flucloxacillin kabi is indicated in adults and children for the following: - the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. - prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Malta - Kiingereza - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - flucloxacillin - powder for solution for infusion or injection - flucloxacillin 1 g - antibacterials for systemic use

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 545 mg (equivalent: flucloxacillin, qty 500 mg) - capsule, hard - excipient ingredients: povidone; titanium dioxide; purified talc; brilliant blue fcf; iron oxide red; magnesium stearate; iron oxide yellow; gelatin; microcrystalline cellulose; sodium starch glycollate - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - flucloxacillin sodium monohydrate, quantity: 272.5 mg (equivalent: flucloxacillin, qty 250 mg) - capsule, hard - excipient ingredients: povidone; brilliant blue fcf; magnesium stearate; sodium starch glycollate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; microcrystalline cellulose; gelatin - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval granted as specified in the letter of 1 may 1992 from dr h. arora. indicated for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections including pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 275mg equivalent to flucloxacillin 250 mg (5% overage);  ;   - capsule - 250 mg - active: flucloxacillin sodium monohydrate 275mg equivalent to flucloxacillin 250 mg (5% overage)     excipient: gelatin iron oxide black iron oxide red iron oxide yellow magnesium stearate opacode titanium dioxide

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 550mg equivalent to flucloxacillin 500 mg (5% overage);  ;   - capsule - 500 mg - active: flucloxacillin sodium monohydrate 550mg equivalent to flucloxacillin 500 mg (5% overage)     excipient: gelatin iron oxide black iron oxide red iron oxide yellow magnesium stearate opacode titanium dioxide

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 1088mg equivalent to 1000 mg flucloxacillin free acid;  ;   - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1088mg equivalent to 1000 mg flucloxacillin free acid    

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 272mg equivalent to 250 mg flucloxacillin free acid;  ;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 272mg equivalent to 250 mg flucloxacillin free acid    

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 544mg equivalent to 500 mg flucloxacillin free acid;  ;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 544mg equivalent to 500 mg flucloxacillin free acid